Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

Navarro WH, Agovi MA, Logan BR, Ballen K, Bolwell BJ, Frangoul H, Gupta V, Hahn T, Ho VT, Juckett M, Lazarus HM, Litzow MR, Liesveld JL, Moreb JS, Marks DI, McCarthy PL, Pasquini MC, Rizzo JD
Biol Blood Marrow Transplant. 2010 16 (10): 1442-50

PMID: 20412867 · PMCID: PMC2933950 · DOI:10.1016/j.bbmt.2010.04.009

MeSH Terms (25)

Acute Disease Adolescent Adult Aged Bone Marrow Transplantation Comorbidity Disease-Free Survival Female Graft vs Host Disease Hematopoietic Stem Cell Transplantation Humans Kaplan-Meier Estimate Leukemia, Myeloid Male Middle Aged Myeloablative Agonists Obesity Overweight Prognosis Retrospective Studies Thinness Transplantation, Homologous Transplantation Conditioning Treatment Outcome Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links